Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of January 2019. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on January 18, 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific financial data. There are no disclosed values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or details on unusual items. The content is limited to the cover page, signature block, and exhibit index.
Investor Verification Checklist
- Verify the content of the attached Press Release (Exhibit 99.1) for specific operational or financial updates.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed in the filing.
- Review subsequent filings for detailed financial statements, as this Form 6-K serves only as a notification of the press release.